ZINC

ZINC was reported 26686 times

These side effects are most commonly reported by patients taking ZINC:

# Side effect Count
0 FATIGUE 2679
1 PAIN 1962
2 NAUSEA 1942
3 DIARRHOEA 1915
4 HEADACHE 1868
5 OFF LABEL USE 1828
6 DRUG INEFFECTIVE 1560
7 DYSPNOEA 1507
8 DIZZINESS 1368
9 ARTHRALGIA 1362
10 FALL 1278
11 ASTHENIA 1264
12 CONSTIPATION 1122
13 RASH 1106
14 COUGH 1020
15 PRURITUS 1001
16 VOMITING 997
17 COVID-19 970
18 PRODUCT DOSE OMISSION ISSUE 969
19 MALAISE 950
20 INSOMNIA 919
21 PAIN IN EXTREMITY 892
22 PNEUMONIA 851
23 WEIGHT DECREASED 841
24 BACK PAIN 790
25 CONDITION AGGRAVATED 788
26 MUSCLE SPASMS 740
27 ALOPECIA 724
28 FEELING ABNORMAL 709
29 NASOPHARYNGITIS 700
30 PYREXIA 673
31 WEIGHT INCREASED 671
32 DECREASED APPETITE 666
33 BALANCE DISORDER 657
34 HYPOTENSION 655
35 ANXIETY 649
36 URINARY TRACT INFECTION 648
37 PERIPHERAL SWELLING 647
38 GAIT DISTURBANCE 630
39 MOBILITY DECREASED 616
40 DEATH 613
41 ABDOMINAL DISCOMFORT 608
42 PRODUCT USE IN UNAPPROVED INDICATION 595
43 ABDOMINAL PAIN UPPER 587
44 HYPERTENSION 581
45 DEPRESSION 579
46 SINUSITIS 574
47 PARAESTHESIA 557
48 ABDOMINAL PAIN 543
49 HYPOAESTHESIA 521
50 BLOOD PRESSURE INCREASED 513
51 MYALGIA 510
52 INJECTION SITE PAIN 498
53 MEMORY IMPAIRMENT 493
54 ABDOMINAL DISTENSION 468
55 SOMNOLENCE 462
56 HYPERSENSITIVITY 461
57 MUSCULAR WEAKNESS 460
58 COGNITIVE DISORDER 458
59 DRUG HYPERSENSITIVITY 449
60 CHEST PAIN 440
61 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 440
62 CONFUSIONAL STATE 435
63 JOINT SWELLING 425
64 ILLNESS 406
65 ERYTHEMA 404
66 MIGRAINE 399
67 ANAEMIA 396
68 MUSCULOSKELETAL STIFFNESS 391
69 CONTUSION 387
70 DRY MOUTH 387
71 URTICARIA 385
72 DYSPEPSIA 383
73 VISION BLURRED 383
74 TREMOR 382
75 CHILLS 371
76 TOXICITY TO VARIOUS AGENTS 366
77 GASTROOESOPHAGEAL REFLUX DISEASE 364
78 BLOOD CALCIUM DECREASED 359
79 DEPRESSED LEVEL OF CONSCIOUSNESS 356
80 ORTHOSTATIC HYPOTENSION 355
81 SEDATION 350
82 OROPHARYNGEAL PAIN 344
83 INFECTION 343
84 WHITE BLOOD CELL COUNT DECREASED 343
85 SLEEP DISORDER 342
86 HOT FLUSH 339
87 ARTHROPATHY 336
88 DEHYDRATION 335
89 SWELLING 335
90 CHEST DISCOMFORT 334
91 PRODUCT USE ISSUE 334
92 DRY SKIN 326
93 NEUROPATHY PERIPHERAL 326
94 CREATININE RENAL CLEARANCE DECREASED 323
95 OSTEOARTHRITIS 319
96 INFLUENZA 316
97 SEDATION COMPLICATION 316
98 PALPITATIONS 309
99 DRUG INTOLERANCE 308
100 GASTROINTESTINAL DISORDER 308
101 LOWER RESPIRATORY TRACT INFECTION 307
102 NECK PAIN 306
103 HEART RATE INCREASED 300
104 RHEUMATOID ARTHRITIS 300
105 BRONCHITIS 298
106 WHEEZING 287
107 INCORRECT DOSE ADMINISTERED 282
108 RHINORRHOEA 282
109 VISUAL IMPAIRMENT 282
110 INTENTIONAL PRODUCT USE ISSUE 279
111 ASTHMA 278
112 OVERDOSE 278
113 STOMATITIS 278
114 INFUSION RELATED REACTION 275
115 OEDEMA PERIPHERAL 274
116 DRUG INTERACTION 266
117 HYPERHIDROSIS 266
118 LOSS OF CONSCIOUSNESS 266
119 DYSPHAGIA 263
120 BLISTER 262
121 HEPATIC ENZYME INCREASED 259
122 PLATELET COUNT DECREASED 258
123 FLUSHING 256
124 BLOOD CHOLESTEROL INCREASED 252
125 SKIN EXFOLIATION 250
126 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 244
127 ARTHRITIS 243
128 INFLAMMATION 243
129 EYE PAIN 240
130 DYSGEUSIA 239
131 STRESS 237
132 GENERAL PHYSICAL HEALTH DETERIORATION 236
133 HAEMOGLOBIN DECREASED 235
134 SEIZURE 231
135 ATRIAL FIBRILLATION 229
136 EPISTAXIS 228
137 BURNING SENSATION 224
138 NASAL CONGESTION 222
139 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 219
140 FLATULENCE 218
141 BLOOD GLUCOSE INCREASED 217
142 SEPSIS 216
143 INTENTIONAL PRODUCT MISUSE 215
144 OXYGEN SATURATION DECREASED 214
145 RENAL FAILURE 213
146 TASTE DISORDER 213
147 LUNG DISORDER 210
148 PSORIASIS 207
149 INFLUENZA LIKE ILLNESS 206
150 NIGHT SWEATS 202
151 THERAPY INTERRUPTED 202
152 WOUND 200
153 PRODUCTIVE COUGH 196
154 DYSPHONIA 193
155 MATERNAL EXPOSURE DURING PREGNANCY 193
156 UPPER RESPIRATORY TRACT INFECTION 191
157 GAIT INABILITY 190
158 PRODUCT QUALITY ISSUE 190
159 PSORIATIC ARTHROPATHY 190
160 BONE PAIN 189
161 FEELING HOT 189
162 HOSPITALISATION 188
163 MUSCULOSKELETAL PAIN 187
164 THROMBOSIS 187
165 HALLUCINATION 186
166 INJECTION SITE ERYTHEMA 186
167 THERAPEUTIC PRODUCT EFFECT DECREASED 185
168 DRY EYE 183
169 ILL-DEFINED DISORDER 181
170 BLOOD PRESSURE DECREASED 178
171 CEREBROVASCULAR ACCIDENT 176
172 IMPAIRED HEALING 175
173 OBESITY 175
174 PRODUCT SUBSTITUTION ISSUE 174
175 THROAT IRRITATION 174
176 ACUTE KIDNEY INJURY 173
177 OEDEMA 173
178 SEASONAL ALLERGY 172
179 SYNCOPE 171
180 DISEASE RECURRENCE 170
181 POLLAKIURIA 170
182 FIBROMYALGIA 164
183 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 164
184 HERPES ZOSTER 163
185 IRRITABLE BOWEL SYNDROME 163
186 DIABETES MELLITUS 160
187 SUICIDAL IDEATION 160
188 INJURY 159
189 INJECTION SITE BRUISING 157
190 CARDIAC DISORDER 156
191 CELLULITIS 156
192 HAEMORRHAGE 156
193 ADVERSE DRUG REACTION 155
194 CHRONIC KIDNEY DISEASE 153
195 TYPE 2 DIABETES MELLITUS 153
196 VERTIGO 153
197 FLUID RETENTION 152
198 LIMB INJURY 151
199 DRUG ABUSE 150
200 DISEASE PROGRESSION 149
201 DYSPNOEA EXERTIONAL 149
202 TINNITUS 147
203 LETHARGY 146
204 OSTEOPOROSIS 146
205 TREATMENT FAILURE 146
206 AMNESIA 145
207 ECZEMA 145
208 INJECTION SITE REACTION 145
209 MYOCARDIAL INFARCTION 145
210 THERAPY CESSATION 145
211 DISCOMFORT 144
212 DYSSTASIA 144
213 SYSTEMIC LUPUS ERYTHEMATOSUS 143
214 EYE IRRITATION 142
215 PULMONARY EMBOLISM 141
216 RASH PRURITIC 141
217 NEPHROLITHIASIS 140
218 FOETAL EXPOSURE DURING PREGNANCY 138
219 OCULAR HYPERAEMIA 136
220 KNEE ARTHROPLASTY 135
221 EAR PAIN 133
222 JOINT RANGE OF MOTION DECREASED 133
223 SKIN DISORDER 133
224 CATARACT 132
225 BLOOD POTASSIUM DECREASED 131
226 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 131
227 SKIN DISCOLOURATION 131
228 CONGENITAL ANOMALY 130
229 LIVER FUNCTION TEST INCREASED 130
230 SYNOVITIS 130
231 UNEVALUABLE EVENT 130
232 WOUND INFECTION 130
233 C-REACTIVE PROTEIN INCREASED 129
234 DISTURBANCE IN ATTENTION 129
235 LIVER INJURY 129
236 SINUS DISORDER 129
237 INJECTION SITE SWELLING 128
238 FUNGAL INFECTION 127
239 IRRITABILITY 127
240 ORAL PAIN 127
241 TACHYCARDIA 127
242 SWELLING FACE 126
243 CARDIAC FAILURE CONGESTIVE 125
244 JOINT STIFFNESS 123
245 NEURALGIA 123
246 CROHN^S DISEASE 122
247 DEPRESSED MOOD 122
248 DEVICE ISSUE 121
249 DYSURIA 121
250 UNDERDOSE 121
251 GLOSSODYNIA 120
252 NAIL DISORDER 119
253 SNEEZING 119
254 SPEECH DISORDER 117
255 DERMATITIS ATOPIC 116
256 RED BLOOD CELL COUNT DECREASED 116
257 VIRAL INFECTION 116
258 BLOOD CREATININE INCREASED 115
259 BRAIN FOG 115
260 NEUTROPENIA 115
261 ONYCHOMYCOSIS 115
262 BACK INJURY 114
263 PHOTOPHOBIA 113
264 THERAPY NON-RESPONDER 113
265 FEELING COLD 112
266 INJECTION SITE HAEMORRHAGE 112
267 PRODUCT DOSE OMISSION IN ERROR 112
268 MUSCLE INJURY 111
269 BURSITIS 110
270 EPILEPSY 110
271 PERIPHERAL VENOUS DISEASE 110
272 MALIGNANT NEOPLASM PROGRESSION 109
273 PULMONARY PAIN 109
274 RENAL IMPAIRMENT 109
275 FINGER DEFORMITY 108
276 PLEURAL EFFUSION 108
277 RENAL DISORDER 108
278 DRUG-INDUCED LIVER INJURY 107
279 EXPOSURE DURING PREGNANCY 107
280 HAEMATOCHEZIA 107
281 INSURANCE ISSUE 107
282 URINARY INCONTINENCE 107
283 DRUG DOSE OMISSION 106
284 EAR INFECTION 106
285 INJECTION SITE PRURITUS 106
286 THERAPEUTIC RESPONSE UNEXPECTED 106
287 HYPERCHOLESTEROLAEMIA 104
288 EYE SWELLING 103
289 LYMPHADENOPATHY 103
290 MULTIPLE SCLEROSIS RELAPSE 103
291 NERVOUSNESS 103
292 SCIATICA 103
293 CYSTITIS 102
294 LIP DRY 102
295 PERICARDITIS 102
296 AGITATION 100
297 CONTRAINDICATED PRODUCT ADMINISTERED 100
298 DYSARTHRIA 100
299 INTENTIONAL DOSE OMISSION 100
300 RHEUMATIC FEVER 100
301 LIVER DISORDER 99
302 MOVEMENT DISORDER 99
303 GRIP STRENGTH DECREASED 98
304 HAND DEFORMITY 98
305 INFUSION SITE PAIN 98
306 LACRIMATION INCREASED 98
307 SURGERY 98
308 BLEPHAROSPASM 97
309 FULL BLOOD COUNT DECREASED 97
310 HELICOBACTER INFECTION 97
311 PAIN IN JAW 97
312 PRODUCT LABEL CONFUSION 97
313 RESPIRATORY TRACT INFECTION 97
314 THROMBOCYTOPENIA 97
315 FREQUENT BOWEL MOVEMENTS 96
316 HEPATITIS 96
317 ACNE 95
318 EMOTIONAL DISTRESS 95
319 FOLLICULITIS 95
320 JOINT INJURY 95
321 ONYCHOMADESIS 95
322 PANIC ATTACK 95
323 ROAD TRAFFIC ACCIDENT 95
324 SKIN LACERATION 95
325 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 94
326 HYPERSOMNIA 93
327 HYPOACUSIS 93
328 PEMPHIGUS 93
329 AGEUSIA 92
330 ALANINE AMINOTRANSFERASE INCREASED 92
331 COLITIS 92
332 FACET JOINT SYNDROME 92
333 BREAST CANCER STAGE III 91
334 INTESTINAL OBSTRUCTION 91
335 DEEP VEIN THROMBOSIS 90
336 HYPONATRAEMIA 90
337 ASPARTATE AMINOTRANSFERASE INCREASED 89
338 MULTIPLE SCLEROSIS 89
339 TRANSIENT ISCHAEMIC ATTACK 89
340 CANDIDA INFECTION 88
341 CARDIAC FAILURE 88
342 CHOLELITHIASIS 88
343 COELIAC DISEASE 88
344 THERAPEUTIC RESPONSE DECREASED 88
345 THINKING ABNORMAL 88
346 ADVERSE EVENT 87
347 NIGHTMARE 87
348 POOR QUALITY SLEEP 87
349 HEAD INJURY 86
350 NEOPLASM MALIGNANT 86
351 SKIN BURNING SENSATION 86
352 SKIN LESION 86
353 ADVERSE REACTION 85
354 HEART RATE DECREASED 85
355 INCORRECT PRODUCT ADMINISTRATION DURATION 85
356 COLITIS ULCERATIVE 84
357 FEBRILE NEUTROPENIA 84
358 RETCHING 84
359 CRYING 83
360 DYSKINESIA 83
361 GASTROINTESTINAL HAEMORRHAGE 83
362 LIVE BIRTH 83
363 RASH MACULAR 83
364 RENAL FUNCTION TEST ABNORMAL 83
365 EYE DISORDER 82
366 RASH ERYTHEMATOUS 82
367 RECTAL HAEMORRHAGE 82
368 RESPIRATORY DISORDER 82
369 TREATMENT NONCOMPLIANCE 82
370 C-REACTIVE PROTEIN ABNORMAL 81
371 HEART RATE IRREGULAR 81
372 HIP FRACTURE 81
373 HYPOAESTHESIA ORAL 81
374 SKIN FISSURES 81
375 WHITE BLOOD CELL COUNT INCREASED 81
376 SLEEP APNOEA SYNDROME 80
377 DISORIENTATION 79
378 DIVERTICULITIS 79
379 GASTROENTERITIS VIRAL 79
380 PANCYTOPENIA 79
381 RESPIRATORY TRACT CONGESTION 79
382 CARDIAC ARREST 78
383 GOUT 78
384 ORAL CANDIDIASIS 78
385 SARS-COV-2 TEST POSITIVE 78
386 ERUCTATION 77
387 HYPOTHYROIDISM 77
388 LIMB DISCOMFORT 77
389 PROCEDURAL PAIN 77
390 TENDERNESS 77
391 ACCIDENTAL EXPOSURE TO PRODUCT 76
392 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 76
393 DRUG DEPENDENCE 76
394 DUODENAL ULCER PERFORATION 76
395 HYPOPHAGIA 76
396 INTERSTITIAL LUNG DISEASE 76
397 ORAL HERPES 76
398 SEPTIC SHOCK 76
399 THERAPEUTIC RESPONSE SHORTENED 76
400 HIATUS HERNIA 75
401 LABORATORY TEST ABNORMAL 75
402 MENTAL DISORDER 75
403 DEMENTIA 74
404 HEAD DISCOMFORT 74
405 LOCALISED INFECTION 74
406 SCAR 74
407 THIRST 74
408 WITHDRAWAL SYNDROME 74
409 BACTERIAL INFECTION 73
410 BODY TEMPERATURE INCREASED 73
411 FEEDING DISORDER 73
412 APHASIA 72
413 ASCITES 72
414 BODY HEIGHT DECREASED 72
415 PRODUCT AVAILABILITY ISSUE 72
416 EMOTIONAL DISORDER 71
417 MULTIPLE ALLERGIES 71
418 NO ADVERSE EVENT 71
419 THROAT TIGHTNESS 71
420 PULMONARY OEDEMA 70
421 TOOTH DISORDER 70
422 BLOOD PRESSURE FLUCTUATION 69
423 BRADYCARDIA 69
424 HAEMOPTYSIS 69
425 PARAESTHESIA ORAL 69
426 RESPIRATORY FAILURE 69
427 BLOOD PRESSURE SYSTOLIC INCREASED 68
428 MUSCULOSKELETAL DISORDER 68
429 STAPHYLOCOCCAL INFECTION 68
430 BLOOD IRON DECREASED 67
431 MIDDLE INSOMNIA 67
432 RESTLESS LEGS SYNDROME 67
433 SKIN ULCER 67
434 BLOOD GLUCOSE DECREASED 66
435 BLOOD URINE PRESENT 66
436 CARPAL TUNNEL SYNDROME 66
437 ERECTILE DYSFUNCTION 66
438 HEPATIC STEATOSIS 66
439 NEUTROPHIL COUNT DECREASED 66
440 SINUS CONGESTION 66
441 DEVICE MALFUNCTION 65
442 EYE PRURITUS 65
443 HAEMATURIA 65
444 RIB FRACTURE 65
445 ANGER 64
446 CHROMATURIA 64
447 DIPLOPIA 64
448 INTERVERTEBRAL DISC PROTRUSION 64
449 MACULAR DEGENERATION 64
450 PRESYNCOPE 64
451 SWOLLEN TONGUE 64
452 ANAPHYLACTIC REACTION 63
453 MOOD SWINGS 63
454 ABNORMAL FAECES 62
455 BLOOD SODIUM DECREASED 62
456 DERMATITIS 62
457 MUSCULOSKELETAL DISCOMFORT 62
458 PRODUCT ADMINISTRATION ERROR 62
459 URINARY RETENTION 62
460 COVID-19 PNEUMONIA 61
461 FAECES DISCOLOURED 61
462 MULTIPLE DRUG THERAPY 61
463 PRODUCT USE COMPLAINT 61
464 CORONARY ARTERY DISEASE 60
465 DERMATITIS CONTACT 60
466 MULTIPLE ORGAN DYSFUNCTION SYNDROME 60
467 MUSCLE TIGHTNESS 60
468 NEOPLASM PROGRESSION 60
469 POST PROCEDURAL COMPLICATION 59
470 TENDONITIS 59
471 VAGINAL HAEMORRHAGE 59
472 AGGRESSION 58
473 BACK DISORDER 58
474 BLOOD PRESSURE ABNORMAL 58
475 CLOSTRIDIUM DIFFICILE INFECTION 58
476 CONJUNCTIVITIS 58
477 HAEMATOCRIT DECREASED 58
478 HERNIA 58
479 MUSCULOSKELETAL CHEST PAIN 58
480 PANCREATITIS 58
481 PLASMA CELL MYELOMA 58
482 APPETITE DISORDER 57
483 GASTROINTESTINAL PAIN 57
484 HYPOXIA 57
485 INFUSION SITE ERYTHEMA 57
486 PAIN OF SKIN 57
487 ANAL INCONTINENCE 56
488 FOOT DEFORMITY 56
489 INFUSION SITE SWELLING 56
490 SECRETION DISCHARGE 56
491 SKIN ATROPHY 56
492 TOOTHACHE 56
493 BLOOD TEST ABNORMAL 55
494 BREAST CANCER 55
495 LIP SWELLING 55
496 LUNG NEOPLASM MALIGNANT 55
497 MEDICATION ERROR 55
498 SPINAL FRACTURE 55
499 ULCER 55
500 AMYLOID ARTHROPATHY 54
501 APLASTIC ANAEMIA 54
502 IMPAIRED QUALITY OF LIFE 54
503 PRODUCT DOSE OMISSION 54
504 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 54
505 THYROID DISORDER 54
506 WRIST FRACTURE 54
507 HIDRADENITIS 53
508 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 53
509 INJECTION SITE MASS 53
510 INTERVERTEBRAL DISC DEGENERATION 53
511 LARYNGITIS 53
512 MENTAL STATUS CHANGES 53
513 NERVOUS SYSTEM DISORDER 53
514 PRODUCT STORAGE ERROR 53
515 SKIN HAEMORRHAGE 53
516 BASAL CELL CARCINOMA 52
517 DIZZINESS POSTURAL 52
518 MICTURITION URGENCY 52
519 NASAL POLYPS 52
520 SENSORY DISTURBANCE 52
521 SPINAL PAIN 52
522 WEIGHT FLUCTUATION 52
523 ABNORMAL DREAMS 51
524 CREATININE RENAL CLEARANCE INCREASED 51
525 EATING DISORDER 51
526 GASTRIC DISORDER 51
527 GASTRITIS 51
528 INCREASED APPETITE 51
529 NOCTURIA 51
530 PERIPHERAL COLDNESS 51
531 RESTLESSNESS 51
532 UPPER LIMB FRACTURE 51
533 ABNORMAL BEHAVIOUR 50
534 ANOSMIA 50
535 HEPATIC CIRRHOSIS 50
536 HYPOKALAEMIA 50
537 IMMUNODEFICIENCY 50
538 KIDNEY INFECTION 50
539 MOOD ALTERED 50
540 MUSCLE TWITCHING 50
541 MYASTHENIA GRAVIS 50
542 OSTEOMYELITIS 50
543 SKIN WARM 50
544 UPPER-AIRWAY COUGH SYNDROME 50
545 ARRHYTHMIA 49
546 BLADDER DISORDER 49
547 END STAGE RENAL DISEASE 49
548 EXOSTOSIS 49
549 EXTRA DOSE ADMINISTERED 49
550 EYE INFECTION 49
551 IMPAIRED WORK ABILITY 49
552 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 49
553 LOWER LIMB FRACTURE 49
554 OBSTRUCTIVE AIRWAYS DISORDER 49
555 PRESCRIBED UNDERDOSE 49
556 PULMONARY FIBROSIS 49
557 ACUTE RESPIRATORY FAILURE 48
558 ANGINA PECTORIS 48
559 APHONIA 48
560 EXPIRED PRODUCT ADMINISTERED 48
561 SJOGREN^S SYNDROME 48
562 SPINAL OSTEOARTHRITIS 48
563 BLINDNESS 47
564 BLOOD CALCIUM INCREASED 47
565 BLOOD MAGNESIUM DECREASED 47
566 DEVICE DISLOCATION 47
567 HYPOGLYCAEMIA 47
568 IRON DEFICIENCY ANAEMIA 47
569 MENTAL IMPAIRMENT 47
570 MOUTH ULCERATION 47
571 MUSCLE ATROPHY 47
572 OCULAR DISCOMFORT 47
573 PULMONARY HYPERTENSION 47
574 SCAB 47
575 SKIN IRRITATION 47
576 TOOTH INFECTION 47
577 ARTHRITIS INFECTIVE 46
578 BONE DENSITY DECREASED 46
579 FEMUR FRACTURE 46
580 FULL BLOOD COUNT ABNORMAL 46
581 HALLUCINATION, VISUAL 46
582 MUSCLE SPASTICITY 46
583 PNEUMONITIS 46
584 PRODUCT ADMINISTRATION INTERRUPTED 46
585 CHOKING 45
586 FEAR 45
587 HYPOKINESIA 45
588 IMMUNE SYSTEM DISORDER 45
589 MUSCLE STRAIN 45
590 PLATELET COUNT INCREASED 45
591 WOUND SECRETION 45
592 ABDOMINAL PAIN LOWER 44
593 BONE DISORDER 44
594 DEAFNESS 44
595 DRUG WITHDRAWAL SYNDROME 44
596 HAEMORRHAGIC DIATHESIS 44
597 LIGAMENT SPRAIN 44
598 RENAL CYST 44
599 VITAMIN D DEFICIENCY 44
600 APPENDICITIS 43
601 BRONCHIECTASIS 43
602 EMPHYSEMA 43
603 FOOD POISONING 43
604 HAEMORRHOIDS 43
605 HEPATIC ENCEPHALOPATHY 43
606 HYPOPHOSPHATAEMIA 43
607 INJECTION SITE RASH 43
608 ANHEDONIA 42
609 BLOOD URIC ACID INCREASED 42
610 CEREBRAL HAEMORRHAGE 42
611 CHRONIC SINUSITIS 42
612 DELIRIUM 42
613 EAR DISCOMFORT 42
614 HAIR TEXTURE ABNORMAL 42
615 LYMPHOEDEMA 42
616 NEEDLE ISSUE 42
617 NODULE 42
618 PARANASAL SINUS DISCOMFORT 42
619 PAROSMIA 42
620 PHOTOSENSITIVITY REACTION 42
621 SENSITIVE SKIN 42
622 SKIN CANCER 42
623 DRUG EFFECT DECREASED 41
624 FEELING JITTERY 41
625 MALNUTRITION 41
626 RALES 41
627 RENAL PAIN 41
628 RESPIRATORY DISTRESS 41
629 ROTATOR CUFF SYNDROME 41
630 SINUS PAIN 41
631 CARDIOGENIC SHOCK 40
632 DENTAL CARIES 40
633 GLYCOSYLATED HAEMOGLOBIN INCREASED 40
634 INCREASED TENDENCY TO BRUISE 40
635 JAUNDICE 40
636 PALLOR 40
637 PRODUCT DISTRIBUTION ISSUE 40
638 PRODUCT PRESCRIBING ERROR 40
639 PSEUDOMONAS INFECTION 40
640 QUALITY OF LIFE DECREASED 40
641 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 40
642 ANKLE FRACTURE 39
643 BEDRIDDEN 39
644 DECREASED ACTIVITY 39
645 DISABILITY 39
646 FOOD ALLERGY 39
647 FOOT FRACTURE 39
648 HYPERLIPIDAEMIA 39
649 INFUSION SITE DISCHARGE 39
650 INITIAL INSOMNIA 39
651 MUCOSAL INFLAMMATION 39
652 PARKINSON^S DISEASE 39
653 TENDON PAIN 39
654 AMMONIA INCREASED 38
655 EXPOSURE VIA SKIN CONTACT 38
656 GALLBLADDER DISORDER 38
657 PHARYNGEAL SWELLING 38
658 RHABDOMYOLYSIS 38
659 THERAPY CHANGE 38
660 VITAMIN D DECREASED 38
661 BLOOD ALKALINE PHOSPHATASE INCREASED 37
662 BLOOD POTASSIUM INCREASED 37
663 CONVULSION 37
664 DEVICE RELATED INFECTION 37
665 DRUG EFFECT LESS THAN EXPECTED 37
666 GLAUCOMA 37
667 INTERNATIONAL NORMALISED RATIO INCREASED 37
668 LIVER FUNCTION TEST ABNORMAL 37
669 OROPHARYNGEAL DISCOMFORT 37
670 OVERWEIGHT 37
671 POST PROCEDURAL INFECTION 37
672 SEROTONIN SYNDROME 37
673 SLUGGISHNESS 37
674 ACTIVITIES OF DAILY LIVING IMPAIRED 36
675 APATHY 36
676 COLD SWEAT 36
677 HAEMATOMA 36
678 HYPERKALAEMIA 36
679 INFUSION SITE HAEMORRHAGE 36
680 ORAL DISCOMFORT 36
681 OSTEOPENIA 36
682 PULMONARY CONGESTION 36
683 PURPURA 36
684 SALIVARY HYPERSECRETION 36
685 SPLENOMEGALY 36
686 APPLICATION SITE PAIN 35
687 DEVICE DIFFICULT TO USE 35
688 FACIAL PAIN 35
689 GINGIVAL BLEEDING 35
690 INFUSION SITE PRURITUS 35
691 LEUKOPENIA 35
692 LYMPHOCYTE COUNT DECREASED 35
693 RENAL FAILURE ACUTE 35
694 SKIN INFECTION 35
695 BLOOD TRIGLYCERIDES INCREASED 34
696 DECUBITUS ULCER 34
697 DEVICE LEAKAGE 34
698 DRY THROAT 34
699 HEPATIC FAILURE 34
700 MENISCUS INJURY 34
701 NERVE INJURY 34
702 PHARYNGITIS STREPTOCOCCAL 34
703 PNEUMONIA BACTERIAL 34
704 PULMONARY MASS 34
705 RASH PAPULAR 34
706 TEMPERATURE INTOLERANCE 34
707 TUMOUR MARKER INCREASED 34
708 VENTRICULAR FIBRILLATION 34
709 VITREOUS FLOATERS 34
710 ABSCESS 33
711 DIASTOLIC DYSFUNCTION 33
712 FAECES SOFT 33
713 FEMALE GENITAL TRACT FISTULA 33
714 GASTRIC ULCER 33
715 GINGIVAL PAIN 33
716 HYPERAESTHESIA 33
717 IMPAIRED GASTRIC EMPTYING 33
718 INCONTINENCE 33
719 INFUSION SITE BRUISING 33
720 MASS 33
721 TOOTH FRACTURE 33
722 TRANSFUSION 33
723 BLOOD BILIRUBIN INCREASED 32
724 BLOOD UREA INCREASED 32
725 COORDINATION ABNORMAL 32
726 INABILITY TO AFFORD MEDICATION 32
727 NEPHROPATHY 32
728 PROCEDURAL COMPLICATION 32
729 PRODUCT PRESCRIBING ISSUE 32
730 PYELONEPHRITIS 32
731 RED BLOOD CELL SEDIMENTATION RATE INCREASED 32
732 RESPIRATORY SYMPTOM 32
733 WOUND COMPLICATION 32
734 APPLICATION SITE PRURITUS 31
735 AUTOIMMUNE DISORDER 31
736 BLOOD COUNT ABNORMAL 31
737 COMPLICATION ASSOCIATED WITH DEVICE 31
738 DYSPHORIA 31
739 FISTULA 31
740 FLANK PAIN 31
741 HYPERGLYCAEMIA 31
742 IRON DEFICIENCY 31
743 PRODUCT TASTE ABNORMAL 31
744 SCHIZOPHRENIA 31
745 SENSATION OF FOREIGN BODY 31
746 SKIN ODOUR ABNORMAL 31
747 SPINAL STENOSIS 31
748 SWELLING OF EYELID 31
749 TROPONIN INCREASED 31
750 APHTHOUS ULCER 30
751 APPLICATION SITE ERYTHEMA 30
752 BLOOD TESTOSTERONE DECREASED 30
753 BLOOD THYROID STIMULATING HORMONE INCREASED 30
754 BODY TEMPERATURE DECREASED 30
755 BOWEL MOVEMENT IRREGULARITY 30
756 DIVERTICULUM 30
757 DRUG EFFECT INCOMPLETE 30
758 DYSLIPIDAEMIA 30
759 EAR CONGESTION 30
760 EYE DISCHARGE 30
761 GENERALISED OEDEMA 30
762 HERPES VIRUS INFECTION 30
763 HIP ARTHROPLASTY 30
764 HOSPICE CARE 30
765 IMPAIRED DRIVING ABILITY 30
766 NERVE COMPRESSION 30
767 NORMAL NEWBORN 30
768 PELVIC PAIN 30
769 POOR VENOUS ACCESS 30
770 PRE-EXISTING CONDITION IMPROVED 30
771 PROSTATIC SPECIFIC ANTIGEN INCREASED 30
772 RHINOCEREBRAL MUCORMYCOSIS 30
773 SCRATCH 30
774 SMALL INTESTINAL OBSTRUCTION 30
775 UNRESPONSIVE TO STIMULI 30
776 VASCULAR DEVICE INFECTION 30
777 WALKING AID USER 30
778 ARTHROPOD BITE 29
779 CORONARY ARTERY OCCLUSION 29
780 DELUSION 29
781 DRUG ADMINISTRATION ERROR 29
782 PRESCRIBED OVERDOSE 29
783 PRODUCT PHYSICAL ISSUE 29
784 THERAPY PARTIAL RESPONDER 29
785 TOOTH ABSCESS 29
786 CARDIAC FLUTTER 28
787 CYST 28
788 ECONOMIC PROBLEM 28
789 EPIGASTRIC DISCOMFORT 28
790 HUNGER 28
791 LEUKOCYTOSIS 28
792 OSTEONECROSIS 28
793 PARANOIA 28
794 PNEUMONIA ASPIRATION 28
795 PNEUMOTHORAX 28
796 PROSTATOMEGALY 28
797 PULMONARY THROMBOSIS 28
798 RADIATION INFLAMMATION 28
799 TENDON RUPTURE 28
800 ACCIDENT 27
801 APPENDICOLITH 27
802 ATRIAL FLUTTER 27
803 CYANOSIS 27
804 DEVICE BREAKAGE 27
805 ENDOMETRIAL CANCER 27
806 EXERCISE TOLERANCE DECREASED 27
807 FRUSTRATION TOLERANCE DECREASED 27
808 GASTROINTESTINAL INFECTION 27
809 GLOMERULAR FILTRATION RATE DECREASED 27
810 HEMIPARESIS 27
811 HICCUPS 27
812 HYSTERECTOMY 27
813 INJECTION SITE URTICARIA 27
814 PERICARDIAL EFFUSION 27
815 PHARYNGITIS 27
816 POLYURIA 27
817 PRODUCT COMPLAINT 27
818 PRURITUS GENERALISED 27
819 PSYCHIATRIC SYMPTOM 27
820 PSYCHOTIC DISORDER 27
821 ROSACEA 27
822 SKIN PAPILLOMA 27
823 SPINAL DISORDER 27
824 SPUTUM INCREASED 27
825 SYMPTOM RECURRENCE 27
826 TRICUSPID VALVE INCOMPETENCE 27
827 VISUAL ACUITY REDUCED 27
828 ACCIDENTAL OVERDOSE 26
829 AORTIC STENOSIS 26
830 ARTERIOSCLEROSIS 26
831 BLOOD PHOSPHORUS INCREASED 26
832 ELECTROLYTE IMBALANCE 26
833 FIBROSIS 26
834 HYPOTHALAMO-PITUITARY DISORDER 26
835 LOSS OF LIBIDO 26
836 MANIA 26
837 METABOLIC ACIDOSIS 26
838 NASAL DISCOMFORT 26
839 ONYCHOCLASIS 26
840 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 26
841 PARALYSIS 26
842 PARANASAL SINUS HYPERSECRETION 26
843 PELVIC FRACTURE 26
844 SHOCK 26
845 BREAST PAIN 25
846 CHOLECYSTECTOMY 25
847 DEFAECATION URGENCY 25
848 DEVICE USE ISSUE 25
849 DYSTONIA 25
850 EYELID PAIN 25
851 HAIR COLOUR CHANGES 25
852 HEPATIC FUNCTION ABNORMAL 25
853 INTERNAL HAEMORRHAGE 25
854 LYMPHOMA 25
855 MALIGNANT MELANOMA 25
856 MITRAL VALVE INCOMPETENCE 25
857 NASAL DRYNESS 25
858 PERIORBITAL SWELLING 25
859 PRODUCT FORMULATION ISSUE 25
860 SEXUAL DYSFUNCTION 25
861 SINUSITIS FUNGAL 25
862 SPINAL OPERATION 25
863 SPUTUM DISCOLOURED 25
864 SUSPECTED COVID-19 25
865 URINE OUTPUT DECREASED 25
866 UVEITIS 25
867 VAGINAL DISCHARGE 25
868 ABASIA 24
869 BACTERAEMIA 24
870 CARDIO-RESPIRATORY ARREST 24
871 DECREASED INTEREST 24
872 DRUG DOSE OMISSION BY DEVICE 24
873 GASTROINTESTINAL INFLAMMATION 24
874 GENITAL PAIN 24
875 IMMUNOSUPPRESSION 24
876 INCORRECT DRUG ADMINISTRATION DURATION 24
877 INCORRECT DRUG ADMINISTRATION RATE 24
878 JAW DISORDER 24
879 PHARYNGEAL OEDEMA 24
880 PREMATURE BABY 24
881 PRODUCT PREPARATION ERROR 24
882 PRODUCT SUPPLY ISSUE 24
883 SINUS HEADACHE 24
884 SKIN SWELLING 24
885 SUICIDE ATTEMPT 24
886 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 23
887 ADRENAL INSUFFICIENCY 23
888 BETA HAEMOLYTIC STREPTOCOCCAL INFECTION 23
889 BLADDER PAIN 23
890 COAGULOPATHY 23
891 CONCUSSION 23
892 CORONAVIRUS INFECTION 23
893 EAR DISORDER 23
894 ENCEPHALOPATHY 23
895 EYE INFLAMMATION 23
896 FAILURE TO THRIVE 23
897 FOREIGN BODY SENSATION IN EYES 23
898 GROIN PAIN 23
899 HAEMOGLOBIN INCREASED 23
900 HAIR GROWTH ABNORMAL 23
901 HORDEOLUM 23
902 INFUSION SITE REACTION 23
903 MUSCLE RIGIDITY 23
904 OESOPHAGITIS 23
905 POLYARTHRITIS 23
906 PULMONARY ARTERIAL HYPERTENSION 23
907 RHINITIS 23
908 SCOLIOSIS 23
909 SQUAMOUS CELL CARCINOMA 23
910 TOOTH EXTRACTION 23
911 TOOTH LOSS 23
912 ULCER HAEMORRHAGE 23
913 VENTRICULAR EXTRASYSTOLES 23
914 VULVOVAGINAL DRYNESS 23
915 BLOOD GLUCOSE ABNORMAL 22
916 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC 22
917 CARDIOMEGALY 22
918 CHOLECYSTITIS 22
919 COPPER DEFICIENCY 22
920 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 22
921 FUNGAL SKIN INFECTION 22
922 GENITAL ULCERATION 22
923 GLOSSITIS 22
924 HAEMOGLOBIN ABNORMAL 22
925 HEART RATE ABNORMAL 22
926 HEPATOMEGALY 22
927 HYPERPHOSPHATAEMIA 22
928 METASTASES TO BONE 22
929 MUSCLE DISORDER 22
930 NEUROLOGICAL DECOMPENSATION 22
931 ORAL DISORDER 22
932 OSTEONECROSIS OF JAW 22
933 PNEUMONIA STREPTOCOCCAL 22
934 RESPIRATORY SYNCYTIAL VIRUS INFECTION 22
935 SQUAMOUS CELL CARCINOMA OF SKIN 22
936 TARDIVE DYSKINESIA 22
937 TONGUE DISCOMFORT 22
938 UPPER GASTROINTESTINAL HAEMORRHAGE 22
939 WRONG TECHNIQUE IN DRUG USAGE PROCESS 22
940 ABDOMINAL MASS 21
941 ACUTE MYOCARDIAL INFARCTION 21
942 ATTENTION DEFICIT HYPERACTIVITY DISORDER 21
943 BLOOD ALBUMIN DECREASED 21
944 BRAIN INJURY 21
945 BRONCHOSPASM 21
946 CARBUNCLE 21
947 DIABETIC NEUROPATHY 21
948 EYE HAEMORRHAGE 21
949 FEELING DRUNK 21
950 HAEMATEMESIS 21
951 HIP SURGERY 21
952 HYPERVOLAEMIA 21
953 INCORRECT DOSE ADMINISTERED BY DEVICE 21
954 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 21
955 INFUSION SITE EXTRAVASATION 21
956 INJECTION SITE DISCOLOURATION 21
957 INJECTION SITE WARMTH 21
958 LIBIDO DECREASED 21
959 LUNG OPACITY 21
960 MONOCLONAL IMMUNOGLOBULIN PRESENT 21
961 NECROSIS ISCHAEMIC 21
962 OESOPHAGEAL DISORDER 21
963 PANCREATITIS ACUTE 21
964 PETECHIAE 21
965 POLYMYALGIA RHEUMATICA 21
966 PRODUCT ADMINISTRATION ISSUE 21
967 PROSTATE CANCER 21
968 RESPIRATORY ARREST 21
969 TOTAL LUNG CAPACITY DECREASED 21
970 VASCULITIS 21
971 VITAMIN B12 DECREASED 21
972 YELLOW SKIN 21
973 ASTHENOPIA 20
974 BLADDER SPASM 20
975 BRUXISM 20
976 CLOSTRIDIUM DIFFICILE COLITIS 20
977 CYTOPENIA 20
978 DECREASED IMMUNE RESPONSIVENESS 20
979 DYSPHEMIA 20
980 EYELID MARGIN CRUSTING 20
981 GENITAL HERPES 20
982 HEPATOTOXICITY 20
983 HYPOGAMMAGLOBULINAEMIA 20
984 JOINT DISLOCATION 20
985 LIGAMENT RUPTURE 20
986 MACROCYTOSIS 20
987 MYOPATHY 20
988 POST PROCEDURAL HAEMORRHAGE 20
989 REBOUND EFFECT 20
990 TENDON DISORDER 20
991 URINE ODOUR ABNORMAL 20
992 VARICOSE VEIN 20
993 VENTRICULAR TACHYCARDIA 20
994 WHITE BLOOD CELL COUNT ABNORMAL 20
995 AMENORRHOEA 19
996 AUTOIMMUNE THYROIDITIS 19
997 BLOOD CREATINE PHOSPHOKINASE INCREASED 19
998 CALCULUS URINARY 19
999 CARBOHYDRATE ANTIGEN 125 INCREASED 19